Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVS SR and Duloxetine Effects on Desipramine PK
NCT00366652Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of desvenlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Started Sep 2006; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00366652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366652.